Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Van Cutsem

Showing results (141-150 of 251) with videos related to

Pageof 26
Sort By:
Oncology|February 17, 2005
Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II studyJ-L Van Laethem, Ph Van Maele, C Verslype, et al.
British Journal of Cancer|May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancerT Macarulla, A Cervantes, J Tabernero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive OncologyI Borbath, A Ceratti, C Verslype, et al.
British Journal of Cancer|April 14, 2015
Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trialM Verstraete, A Debucquoy, J Dekervel, et al.
Oncogene|December 22, 1999
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)S Tejpar, F Nollet, C Li, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
Quality assurance and recommendations for quality assessment of screening colonoscopy in BelgiumE Macken, T Moreels, P Pelckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2014
Quality assurance in the treatment of colorectal cancer: the EURECCA initiativeA J Breugom, P G Boelens, C B M van den Broek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsD Arnold, B Lueza, J-Y Douillard, et al.
ESMO Open|June 10, 2022
Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysisT Yoshino, E Van Cutsem, J Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancerP Flamen, E Van Cutsem, A Lerut, et al.
Pageof 26

Showing results (141-150 of 251) with videos related to

Sort By:
Pageof 26
Oncology|February 17, 2005
Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II studyJ-L Van Laethem, Ph Van Maele, C Verslype, et al.
British Journal of Cancer|May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancerT Macarulla, A Cervantes, J Tabernero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive OncologyI Borbath, A Ceratti, C Verslype, et al.
British Journal of Cancer|April 14, 2015
Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trialM Verstraete, A Debucquoy, J Dekervel, et al.
Oncogene|December 22, 1999
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)S Tejpar, F Nollet, C Li, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
Quality assurance and recommendations for quality assessment of screening colonoscopy in BelgiumE Macken, T Moreels, P Pelckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2014
Quality assurance in the treatment of colorectal cancer: the EURECCA initiativeA J Breugom, P G Boelens, C B M van den Broek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsD Arnold, B Lueza, J-Y Douillard, et al.
ESMO Open|June 10, 2022
Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysisT Yoshino, E Van Cutsem, J Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancerP Flamen, E Van Cutsem, A Lerut, et al.
Pageof 26